Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Stem Cell Research

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 52 articles: HTML format

Single Articles

April 2024
1. NAM A, Jain S, Wu C, Campos A, et al
   Integrin alphavbeta3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity.
   Cancer Res. 2024 Apr 8:OF1-OF13. doi: 10.1158/0008-5472.CAN-23-2700.
   PubMed     Abstract available
   
   
   February 2024
2. YAN L, Wu M, Wang T, Yuan H, et al
   Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming that Drives Immune Evasion.
   Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2390.
   PubMed     Abstract available
   
   
   January 2024
3. ZHANG H, Du Z, Tu C, Zhou X, et al
   Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
   Cancer Res. 2024;84:39-55.
   PubMed     Abstract available
   
   
   December 2023
4. XIA L, Liu JY, Yang MY, Zhang XH, et al
   Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells.
   Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
   PubMed     Abstract available
   
   
   November 2023
5. GUO X, Qiu W, Wang C, Qi Y, et al
   Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells.
   Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-0609.
   PubMed     Abstract available
   
   
   September 2023
6. YIN J, Seo Y, Rhim J, Jin X, et al
   Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
   Cancer Res. 2023 Sep 25. doi: 10.1158/0008-5472.CAN-22-3965.
   PubMed     Abstract available
   
   
   August 2023
7. JONES CL
   Turning Down the Temperature on Leukemia Stem Cells.
   Cancer Res. 2023;83:2441-2442.
   PubMed     Abstract available
   
   
   July 2023
8. LI L, Jensen RA
   Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells.
   Cancer Res. 2023;83:2096-2104.
   PubMed     Abstract available
   
   
   June 2023
9. GRIESSINGER E, Pereira-Martins D, Nebout M, Bosc C, et al
   Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold.
   Cancer Res. 2023 Jun 5:CAN-23-1006. doi: 10.1158/0008-5472.CAN-23-1006.
   PubMed     Abstract available
   
   
   
10. LOS-DE VRIES GT, Stathi P, Rutkens R, Hijmering NJ, et al
    Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.
    Cancer Res. 2023;83:1917-1927.
    PubMed     Abstract available
    
    
    April 2023
11. GUETTA-TERRIER C, Karambizi D, Akosman B, Zepecki JP, et al
    Chi3l1 is a modulator of glioma stem cell states and a therapeutic target in glioblastoma.
    Cancer Res. 2023 Apr 27:CAN-21-3629. doi: 10.1158/0008-5472.CAN-21-3629.
    PubMed     Abstract available
    
    
    March 2023
12. HUANG X, Zhang S, Tang J, Tian T, et al
    A self-propagating c-Met-SOX2 axis drives cancer-derived IgG signaling that promotes lung cancer cell stemness.
    Cancer Res. 2023 Mar 29:CAN-22-2733. doi: 10.1158/0008-5472.CAN-22-2733.
    PubMed     Abstract available
    
    
    
13. CHAKRAVARTI M, Dhar S, Bera S, Sinha A, et al
    Terminally exhausted CD8+ T cells resistant to PD-1 blockade promote generation and maintenance of aggressive cancer stem cells.
    Cancer Res. 2023 Mar 27:CAN-22-3864. doi: 10.1158/0008-5472.CAN-22-3864.
    PubMed     Abstract available
    
    
    
14. BOO HJ, Min HY, Park CS, Park JS, et al
    Dual impact of IGF2 on alveolar stem cell function during tobacco-induced injury repair and development of pulmonary emphysema and cancer.
    Cancer Res. 2023 Mar 27:CAN-22-3543. doi: 10.1158/0008-5472.CAN-22-3543.
    PubMed     Abstract available
    
    
    
15. ZAMLER DB, Hu J
    Primitive Oligodendrocyte Precursor Cells Are Highly Susceptible to Gliomagenic Transformation.
    Cancer Res. 2023;83:807-808.
    PubMed     Abstract available
    
    
    
16. OKA T, Higa T, Sugahara O, Koga D, et al
    Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence After Chemotherapy of Intestinal Tumors.
    Cancer Res. 2023 Mar 7:CAN-22-2578. doi: 10.1158/0008-5472.CAN-22-2578.
    PubMed     Abstract available
    
    
    January 2023
17. LAN L, Behrens A
    Are There Specific Cancer Stem Cell Markers?
    Cancer Res. 2023;83:170-172.
    PubMed     Abstract available
    
    
    December 2022
18. ADEBAYO AK, Nakshatri H
    Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation.
    Cancer Res. 2022;82:4313-4321.
    PubMed     Abstract available
    
    
    November 2022
19. PIERI V, Gallotti AL, Drago D, Cominelli M, et al
    Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma.
    Cancer Res. 2022 Nov 21:CAN-22-0677. doi: 10.1158/0008-5472.CAN-22-0677.
    PubMed     Abstract available
    
    
    
20. STEVENS LE, Peluffo G, Qiu X, Temko D, et al
    JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states.
    Cancer Res. 2022 Nov 21:CAN-22-0423. doi: 10.1158/0008-5472.CAN-22-0423.
    PubMed     Abstract available
    
    
    
21. MARSHALL CH, Gondek LP, Luo J, Antonarakis ES, et al
    Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Cancer Res. 2022;82:4107-4113.
    PubMed     Abstract available
    
    
    
22. PERRONE M, Chiodoni C, Lecchi M, Botti L, et al
    ATF3 reprograms the bone marrow niche in response to early breast cancer transformation.
    Cancer Res. 2022 Nov 1. pii: 710151. doi: 10.1158/0008-5472.CAN-22-0651.
    PubMed     Abstract available
    
    
    October 2022
23. ATIYA HI, Frisbie L, Goldfeld E, Orellana T, et al
    Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation.
    Cancer Res. 2022 Oct 11. pii: 709712. doi: 10.1158/0008-5472.CAN-22-1294.
    PubMed     Abstract available
    
    
    September 2022
24. FUJISHITA T, Kojima Y, Kajino-Sakamoto R, Mishiro-Sato E, et al
    The cAMP/PKA/CREB and TGF-beta/SMAD4 pathways regulate stemness and metastatic potential in colorectal cancer cells.
    Cancer Res. 2022 Sep 6. pii: 708953. doi: 10.1158/0008-5472.CAN-22-1369.
    PubMed     Abstract available
    
    
    July 2022
25. LI Y, Wang T, Wan Q, Wang Q, et al
    TRAF4 maintains deubiquitination of Caveolin-1 to drive glioblastoma stemness and Temozolomide resistance.
    Cancer Res. 2022 Jul 27. pii: 707286. doi: 10.1158/0008-5472.CAN-21-3882.
    PubMed     Abstract available
    
    
    
26. DHANYAMRAJU PK, Schell TD, Amin S, Robertson GP, et al
    Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
    Cancer Res. 2022;82:2503-2514.
    PubMed     Abstract available
    
    
    
27. LI D, Zhang Q, Li L, Chen K, et al
    beta2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages.
    Cancer Res. 2022 Jul 15. pii: 707040. doi: 10.1158/0008-5472.CAN-22-0507.
    PubMed     Abstract available
    
    
    June 2022
28. MOK EH, Leung CO, Zhou L, Lei MML, et al
    Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma.
    Cancer Res. 2022 Jun 29. pii: 705310. doi: 10.1158/0008-5472.CAN-21-2934.
    PubMed     Abstract available
    
    
    May 2022
29. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
    Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
    Cancer Res. 2022;82:1953-1968.
    PubMed     Abstract available
    
    
    
30. LEBLEU VS
    Plasticity Enables Cooperation among Heterogeneous Cancer Cell Populations to Support Metastatic Fitness.
    Cancer Res. 2022;82:1870-1871.
    PubMed     Abstract available
    
    
    April 2022
31. WANG H, Xu H, Chen W, Cheng M, et al
    Rab13 sustains breast cancer stem cells by supporting tumor-stroma crosstalk.
    Cancer Res. 2022 Apr 8. pii: 694330. doi: 10.1158/0008-5472.CAN-21-4097.
    PubMed     Abstract available
    
    
    March 2022
32. SAMANTA D, Park Y, Andrabi SA, Shelton LM, et al
    Correction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.
    Cancer Res. 2022;82:1153.
    PubMed    
    
    
    
33. OSBORNE JK, Minna JD
    Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications.
    Cancer Res. 2022;82:972-973.
    PubMed     Abstract available
    
    
    February 2022
34. AUZMENDI-IRIARTE J, Otaegi-Ugartemendia M, Carrasco-Garcia E, Azkargorta M, et al
    Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity.
    Cancer Res. 2022 Feb 7. pii: 0008-5472.CAN-21-2161.
    PubMed     Abstract available
    
    
    January 2022
35. YIN H, Jing B, Xu D, Guo W, et al
    Identification of Active Bronchioalveolar Stem Cells as the Cell-of-Origin in Lung Adenocarcinoma.
    Cancer Res. 2022 Jan 19. pii: 0008-5472.CAN-21-2445.
    PubMed     Abstract available
    
    
    November 2021
36. JUNG Y, Cackowski FC, Yumoto K, Decker AM, et al
    Correction: CXCL12gamma Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.
    Cancer Res. 2021;81:5777.
    PubMed    
    
    
    
37. BERLIN C, Cottard F, Willmann D, Urban S, et al
    KMT9 controls stemness and growth of colorectal cancer.
    Cancer Res. 2021 Nov 4. pii: 0008-5472.CAN-21-1261.
    PubMed     Abstract available
    
    
    October 2021
38. FISHER ML, Balinth S, Hwangbo Y, Wu C, et al
    BRD4 REGULATES TRANSCRIPTION FACTOR Np63alphaTO DRIVE A CANCER STEM CELL PHENOTYPE IN SQUAMOUS CELL CARCINOMAS.
    Cancer Res. 2021 Oct 25. pii: 0008-5472.CAN-21-0707.
    PubMed     Abstract available
    
    
    
39. GOLDBERG L, Negi V, Chung YJ, Onozawa M, et al
    Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.
    Cancer Res. 2021;81:5033-5046.
    PubMed     Abstract available
    
    
    September 2021
40. SANJIV K, Calderon-Montano JM, Pham TM, Erkers T, et al
    MTH1 inhibitor TH1579 induces oxidative DNA damage and mitotic arrest in acute myeloid leukemia.
    Cancer Res. 2021 Sep 30. pii: 0008-5472.CAN-21-0061.
    PubMed     Abstract available
    
    
    
41. LIU C, Qiang J, Deng Q, Xia J, et al
    ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression.
    Cancer Res. 2021 Sep 27. pii: 0008-5472.CAN-21-1337.
    PubMed     Abstract available
    
    
    
42. LOH JJ, Li TW, Zhou L, Wong TL, et al
    FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
    Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
    PubMed     Abstract available
    
    
    
43. YANG L, Sun J, Li M, Long Y, et al
    Oxidized low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness.
    Cancer Res. 2021 Sep 3. pii: 0008-5472.CAN-21-0646.
    PubMed     Abstract available
    
    
    August 2021
44. DUTTA A, Nath D, Yang Y, Le BT, et al
    CDK6 Is a Therapeutic Target in Myelofibrosis.
    Cancer Res. 2021;81:4332-4345.
    PubMed     Abstract available
    
    
    July 2021
45. MAIFREDE S, Le BV, Nieborowska-Skorska M, Golovine K, et al
    TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.
    Cancer Res. 2021 Jul 2. pii: 0008-5472.CAN-20-3761.
    PubMed     Abstract available
    
    
    June 2021
46. CANO A, Lopez-Menendez C, Vazquez-Naharro A, Santos V, et al
    E2A modulates stemness, metastasis, and therapeutic resistance of breast cancer.
    Cancer Res. 2021 Jun 18. pii: 0008-5472.CAN-20-2685.
    PubMed     Abstract available
    
    
    May 2021
47. MILLER SA, Policastro RA, Sriramkumar S, Lai T, et al
    LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF mutant colorectal cancer.
    Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-3562.
    PubMed     Abstract available
    
    
    
48. WANG X, Jia Y, Wen L, Mu W, et al
    Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome.
    Cancer Res. 2021;81:2745-2759.
    PubMed     Abstract available
    
    
    
49. FRAU C, Jamard C, Delpouve G, Guardia GDA, et al
    Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
    Cancer Res. 2021;81:2730-2744.
    PubMed     Abstract available
    
    
    
50. LI Y, Wang M, Yang M, Xiao Y, et al
    Nicotine-induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-4160.
    PubMed     Abstract available
    
    
    February 2021
51. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    PubMed     Abstract available
    
    
    January 2021
52. TAMIRO F, Weng AP, Giambra V
    Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-2571.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.